NVIDIA’s work in aiding medical imaging, genomics, and AI-powered robotics was spotlighted at the Precision Medicine World Conference, where founder and CEO Jensen Huang received the prestigious Luminary Award.
During his acceptance, Huang described NVIDIA’s journey over two decades as creating a “computational instrument” designed to empower scientists and researchers in life sciences.
Notably, NVIDIA’s CUDA parallel computing platform, introduced in 2006, was instrumental in demonstrating how GPUs could enhance medical imaging, such as CT reconstruction.
Dr. Gad Getz of Massachusetts General Hospital, acclaimed for his work in cancer genomics, emphasized the pivotal role of NVIDIA’s GPUs in AI and machine learning.
He highlighted that NVIDIA technology today is integral to advances across sequencing technologies, imaging data, proteomics, and molecular dynamics, underpinning developments in large language models used in the medical field.
Huang delved into the future implications of AI in medicine, proposing that AI will fundamentally alter how diseases are predicted, diagnosed, and treated.
With technological progress, AI might enable scanning genomics in seconds or developing digital twins of patients to tailor treatments. He forecasts by 2030 a potential comprehensive understanding and representation of biological cells for predictive purposes.
Moreover, Huang predicted surgical robots increase precision in procedures, AI assistants allow doctors to prioritize patient care, and robotic labs work tirelessly for drug discovery.
Huang among awardees marks special significance as he is the sole representative from the tech sector.
Among other 2025 Luminary Award recipients were Chemistry Nobel Prize winner Carolyn Bertozzi and Stanford University Pediatrics professor Crystal Mackall.